Search All News
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
- November 16, 2021
A Columbia study may lead to stomach cancer screening guidelines, especially for Black and Hispanic Americans who have a greater risk of developing or dying from stomach cancer than white Americans.
- November 12, 2021
Recent observations suggest that surgery is possible for some pancreatic cancer patients who are initially deemed inoperable.
- October 29, 2021
Here’s what Columbia doctors want you to remember when the pink ribbons disappear as breast cancer awareness month ends.
- October 19, 2021
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.
- October 15, 2021
Columbia breast cancer patient Karin Diamond credits regular mammograms for catching her cancer early and her surgeon's use of intraoperative radiation for keeping her cancer-free.
- September 30, 2021
Despite clinical guidelines that advocate surgery as a first step, a Columbia study suggests many patients with advanced ovarian cancer should be treated with chemotherapy before surgery.
- September 29, 2021
Just 17 when diagnosed with advanced cervical cancer, Sheneque Hanse is now in remission after two years of treatment and eager to start a career in health care to help others with cancer.
- September 9, 2021
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.